Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Mohan

Showing results (51-60 of 522) with videos related to

Pageof 53
Sort By:
Trends in Biotechnology|March 31, 2000
Issues in the development of an industrial bioprocess advisory systemJ Glassey, G Montague, P Mohan
British Journal of Urology|September 1, 1994
Neurofibromatous outflow obstructionK P Mohan, J A Massey
Biochemical Pharmacology|February 15, 1991
Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, and reverse transcriptase activityP Mohan, R Singh, M Baba
Oral Oncology|January 26, 2013
An empirical mucosal toxicity measuring tool would elucidate the pattern of mucosal ulceration in cytotoxic therapyP S Satheeshkumar, Minu P Mohan
Oral Oncology|April 23, 2013
Reflectory trismus in head and neck cancerP S Satheeshkumar, Minu P Mohan
Oral Oncology|August 7, 2014
Necessitating a quality of life instrument specific to oral precancers/oral potentially malignant disordersP S Satheeshkumar, Minu P Mohan
Oral Oncology|June 18, 2014
Effective management of oral potentially malignant disorders/precancers - a cost effective strategy for oral cancer prevention in IndiaP S Satheeshkumar, Minu P Mohan
Digestive Diseases and Sciences|July 2, 2014
Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapyP S Satheeshkumar, Minu P Mohan
Gastrointestinal Endoscopy|July 23, 2019
ResponseBabu P Mohan, Douglas G Adler
Oral Oncology|December 4, 2014
A new alimentary tract mucosal inflammation model and a possibility of receptor targeted therapy in tissue reactions in cytotoxic therapyP S Satheeshkumar, Minu P Mohan
Pageof 53

Showing results (51-60 of 522) with videos related to

Sort By:
Pageof 53
Trends in Biotechnology|March 31, 2000
Issues in the development of an industrial bioprocess advisory systemJ Glassey, G Montague, P Mohan
British Journal of Urology|September 1, 1994
Neurofibromatous outflow obstructionK P Mohan, J A Massey
Biochemical Pharmacology|February 15, 1991
Anti-HIV-1 and HIV-2 activity of naphthalenedisulfonic acid derivatives. Inhibition of cytopathogenesis, giant cell formation, and reverse transcriptase activityP Mohan, R Singh, M Baba
Oral Oncology|January 26, 2013
An empirical mucosal toxicity measuring tool would elucidate the pattern of mucosal ulceration in cytotoxic therapyP S Satheeshkumar, Minu P Mohan
Oral Oncology|April 23, 2013
Reflectory trismus in head and neck cancerP S Satheeshkumar, Minu P Mohan
Oral Oncology|August 7, 2014
Necessitating a quality of life instrument specific to oral precancers/oral potentially malignant disordersP S Satheeshkumar, Minu P Mohan
Oral Oncology|June 18, 2014
Effective management of oral potentially malignant disorders/precancers - a cost effective strategy for oral cancer prevention in IndiaP S Satheeshkumar, Minu P Mohan
Digestive Diseases and Sciences|July 2, 2014
Tachykinin peptide, substance P, and its receptor NK-1R play an important role in alimentary tract mucosal inflammation during cytotoxic therapyP S Satheeshkumar, Minu P Mohan
Gastrointestinal Endoscopy|July 23, 2019
ResponseBabu P Mohan, Douglas G Adler
Oral Oncology|December 4, 2014
A new alimentary tract mucosal inflammation model and a possibility of receptor targeted therapy in tissue reactions in cytotoxic therapyP S Satheeshkumar, Minu P Mohan
Pageof 53